Intranasal delivery of morphine

Journal of Pharmacology and Experimental Therapeutics

Volumn 301, Issue 1, 2002, Pages 391-400

  Illum, L ^a   Watts, P ^a   Fisher, A N ^a   Hinchcliffe, M ^a   Norbury, H ^a   Jabbal Gill, I ^a   Nankervis, R ^a   Davis, S S ^a  

^a Drug Delivery and Clinical Research Centre Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; MORPHINE SULFATE;

ADULT; ANALGESIA; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG METABOLISM; DRUG POTENCY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NONHUMAN; NORMAL HUMAN; NOSE; NOSE IRRITATION; NOSE OBSTRUCTION; PRIORITY JOURNAL; RHINORRHEA; SHEEP; SORE THROAT; TASTE DISORDER;

ABSORPTION; ADHESIVES; ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; ANALGESICS, OPIOID; ANIMALS; AREA UNDER CURVE; CHITIN; CHITOSAN; EXCIPIENTS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MICROSPHERES; MORPHINE; NASAL MUCOSA; POWDERS; SHEEP; SOLUTIONS; STARCH;

EID: 0036199859     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.301.1.391     Document Type: Article

References (40)

1. Mucoadhesive drug delivery systems
2. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)
3. Chitosan as a nasal delivery system: Evaluation of the effect of chitosan on mucociliary clearance in the frog palate model
4. The effect of chronic nasal application of chitosan solutions on cilia beat frequency in guinea pigs
5. Chitosan as a nasal delivery system: The effect of chitosan solutions on the in vitro and in vivo mucociliary transport rates in human turbinates and volunteers
6. Experiences and the potential of nasal drug delivery
7. The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III. Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro
8. Study of the bioequivalence of two controlled-release formulations of morphine
9. Les voies d'administration non conventionelles da la morphine
10. Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats
11. Pharmacokinetic and pharmacodynamic issues in the treatment of breakthrough pain
12. Effect of chitosan on epithelial permeability and structure
13. Microspheres as a nasal delivery system for peptide drugs
14. Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain
15. Pain relief into practice: Rhetoric without reform
16. Animal models for nasal delivery
17. Bioadhesive formulations for nasal peptide delivery
18. Chitosan and its use as a pharmaceutical excipient
19. Transport of drugs from the nasal cavity to the central nervous system
20. Nasal administration of morphine-6-glucuronide in sheep - A pharmacokinetic study
21. Chitosan as a novel nasal delivery system for peptide drugs
22. The effect of bioadhesive starch microspheres on the absorption enhancing effect of enhancing agents administered nasally
23. Novel chitosan based delivery systems for nasal administration of a LHRH-analogue
24. Cyclodextrin derivatives that modify nasal absorption of morphine and its entry into cerebrospinal fluid in the rat
25. The contribution of anionic polymer structural features to mucoadhesion
26. Effects of absorption enhancers on rat nasal epithelium in vivo: Release of marker compounds in the nasal cavity
27. An investigation of the effect of anaesthetics on the nasal absorption of insulin in rats
28. Quantitation of benzoylnoreegonine and other cocaine metabolites in meconium by high performance liquid chromatography
29. Morphine and metabolite behaviour after different routes of morphine administration: Demonstration of the importance of the active metabolite morphine-6-glucuronide
30. Pharmacokinetic profile of alniditan nasal spray during and outside migraine attacks
31. Multiple-dose phase I study ofintranasal butorphanol
32. Evaluation of the clearance characteristics of bioadhesive systems in humans
33. Clearance characteristics of chitosan based formulations in the sheep nasal cavity
34. Determination of morphine, morphine3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography
35. Pharmacokinetic comparison of intravenous and intranasal administration of oxycodone
36. Determination of morphine in cerebrospinal fluid and plasma by high-performance liquid chromatography with electrochemical detection
37. Opioids
38. Plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide after intravenous and oral administration to healthy volunteers: Relationship to nonanalgesic actions
39. Nasal morphine for the treatment of breakthrough pain in cancer patients